US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 0.6060
  • -0.0390-6.05%
Close Jan 2 16:00 ET
  • 0.6318
  • +0.0258+4.26%
Post 20:01 ET
4.97MMarket Cap0.00P/E (TTM)

About TC BioPharm Company

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

Company Profile

SymbolTCBP
Company NameTC BioPharm
Listing DateFeb 11, 2022
Issue Price4.24
Founded2021
CEOMr. Bryan Kobel
MarketNASDAQ
Employees41
Securities TypeDR
ADS Ratio1.0 : 200.0
Fiscal Year Ends12-31
AddressMaxim Park 1,2 Parklands Way,Holytown
CityMotherwell
ProvinceNK
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 4WR
Phone44-141-433-7557

Company Executives

  • Name
  • Position
  • Salary
  • Bryan Kobel
  • Chief Executive Officer and Director
  • --
  • Martin Thorp
  • Chief Financial Officer and Director
  • --
  • Arlene M. Morris
  • Independent Director
  • --
  • Anthony James Culverwell
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.